Did Paulson Investments, through Michael McGinley or any other of its Registered Representatives, recommend the purchase of AspenBio Pharma, Inc., for your portfolio? Levin, Papantonio is investigating whether these recommendations were made based on inside information, and whether the information provided by Paulson Investments was accurate.
If you purchased AspenBio Phamra, Inc. based on the recommendations of Paulson Investments and its representatives, you may have a claim against your brokerage firm. Investors who relied on Paulson Investments to construct their portfolios and who held AspenBio Pharma may be entitled to recover their losses. Please contact Peter Mougey at Levin, Papantonio to explore your potential claim.
According to Forbes, Philip Falcone is No. 377 on the list of the 1%, worth $1.2 billion as of March 2013 as well as one of the Top 40 hedge fund managers in the U.S. Except that he won't be doing that anymore - for awhile, anyway.
Author and talk show host Thom Hartmann periodically suggests that it is a form of mental illness – a pathological condition.